US Broker Ratings

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating a 8.83% Potential Upside in Healthcare Innovation

For individual investors looking to delve into the world of healthcare innovation, Becton, Dickinson and Company (NYSE: BDX) presents a compelling opportunity. With a market capitalization..

Novartis AG (NVS) Investor Outlook: Analyzing Market Position Amidst a Strong Dividend Yield and Analyst Ratings

Novartis AG (NYSE: NVS), a global leader in the healthcare sector, stands as a formidable player in the pharmaceutical industry. Based in Switzerland, Novartis is renowned..

Haleon plc (HLN) Stock Analysis: With a 19% Potential Upside, Is This Healthcare Giant a Buy?

Haleon plc (HLN), a major player in the healthcare sector, is making waves in the investment community with its promising potential upside of 19.05%. Based in..

Johnson & Johnson (JNJ) Stock Analysis: Here’s Why Investors Are Eyeing a 5.73% Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. With..

Medtronic plc (MDT) Stock Analysis: Evaluating a 15% Upside Potential Amidst Robust Revenue Growth

Medtronic plc (NYSE: MDT), a global leader in medical devices, has carved a niche in the healthcare sector with an extensive array of innovative products. Headquartered..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating the Healthcare Giant’s 9.61% Potential Upside

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a powerhouse in the healthcare sector, with a commanding market cap of $213.42 billion. As a leader in..

Sanofi (SNY) Stock Analysis: 26.77% Potential Upside with Strong Dividend Yield

Sanofi (SNY), a heavyweight in the healthcare sector, is garnering investor attention with an enticing potential upside of 26.77%, alongside a robust dividend yield of 5.61%...

UnitedHealth Group (UNH) Stock Analysis: Exploring a 14.68% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare plans industry, continues to attract investor attention with its formidable market presence and diversified service offerings...

Standard BioTools Inc. (LAB) Stock Analysis: Uncovering a 72.74% Upside Potential

As investors seek opportunities in the healthcare sector, Standard BioTools Inc. (NASDAQ: LAB) presents a compelling case with its significant upside potential. With a market capitalization..

AtaiBeckley Inc. (ATAI) Stock Analysis: Navigating Challenges with a Potential 33.53% Upside

AtaiBeckley Inc. (NASDAQ: ATAI) stands as a promising player in the biotechnology sector, focusing its efforts on groundbreaking mental health treatments. With a market capitalization of..

Autolus Therapeutics plc (AUTL) Stock Analysis: Exploring a 458.82% Upside Potential in the Biotech Sector

Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company based in London, is capturing attention with its innovative T cell therapies targeting cancer and autoimmune diseases...

Maze Therapeutics, Inc. (MAZE): Analyzing a 126% Potential Upside in Biotech Innovation

Maze Therapeutics, Inc. (NASDAQ: MAZE), a burgeoning name in the biotechnology sector, is capturing investor interest with its impressive potential upside of 126.37%, as indicated by..

Humacyte, Inc. (HUMA) Stock Analysis: A 205% Potential Upside in Innovative Biotechnology

Humacyte, Inc. (NASDAQ: HUMA), a trailblazer in the biotechnology sector, is capturing investor attention with its groundbreaking advancements in bioengineered human tissues. Headquartered in Durham, North..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 77.77% Potential Upside Beckons Biotech Investors

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of biotech investors with its promising potential upside of 77.77%, as indicated by recent analyst ratings. This..

Emergent BioSolutions Inc. (EBS) Stock Analysis: A 65% Upside Potential Despite Challenges

Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector known for its specialized drug manufacturing capabilities, has recently captured the attention of investors..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges and Opportunities with a 16.39% Potential Upside

Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent player in the healthcare sector, particularly in diagnostics and research, is navigating a complex landscape characterized by both challenges..

Abivax SA (ABVX) Stock Analysis: Potential Upside of 33.44% Sparks Investor Interest

Abivax SA (ABVX), a biotechnology company at the forefront of developing treatments for chronic inflammatory diseases, is attracting investor attention with a striking potential upside of..

Personalis, Inc. (PSNL) Stock Analysis: Healthcare Innovator with a 12.99% Upside Potential

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector, is capturing investor attention with its advanced cancer genomic testing services and a potential upside..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 139.85% Potential Upside in the Biotechnology Sector

Investors with an eye on the biotechnology sector might want to pay attention to REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage company specializing in gene therapies. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds